Self-management of vitamin K antagonists is more cost-effective than dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain. Response.
Servicio de Cardiología, Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain.
José R
JR
González-Juanatey
Centro de Salud Jazmín, Área Este, Atención Primaria, Madrid, Spain.
José M
JM
Lobos
Servicio de Hemoterapia y Hemostasia, Hospital Clínic, Barcelona, Spain.
Joan C
JC
Reverter
Departamento de Economía y Resultados en Salud, Boehringer Ingelheim, Barcelona, Spain. Electronic address: virginia.becerra@gmail.com.
Virginia
V
Becerra
D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D001562:Benzimidazoles / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D020521:Stroke / Q000209:etiology* / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D015091:beta-Alanine / Q000031:analogs & derivatives*
D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014812:Vitamin K